179 related articles for article (PubMed ID: 1344999)
1. Immunological and beta-cell-specific characteristics of diabetes-prone BB/OK rats and their congenic derivatives--a comparative study.
Schröder D; Klötting I; Hehmke B; Schmidt S
Diabetes Res; 1992; 20(1):21-31. PubMed ID: 1344999
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains.
Schlosser M; Ziegler B; Augstein P; Klöting I; Ziegler M
Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727
[TBL] [Abstract][Full Text] [Related]
3. In vitro stimulation by islet antigen facilitates the detectability of beta-cell reactive cells in diabetes-prone BB/OK rats.
Wanka H; Kuttler B; Knospe S; Hahn HJ
Autoimmunity; 1999; 30(4):223-34. PubMed ID: 10524498
[TBL] [Abstract][Full Text] [Related]
4. New congenic rat strains for the separate study of MHC and non-MHC genetic effects in the development of diabetes in BB rats.
Kloeting I; Vogt L; Reetz IC; Wurst ; Hedrich HJ; Guenther E
Diabetes Res; 1990 Sep; 15(1):41-5. PubMed ID: 1983425
[TBL] [Abstract][Full Text] [Related]
5. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
[TBL] [Abstract][Full Text] [Related]
6. Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulin-dependent diabetes mellitus.
van den Brandt J; Kovács P; Klöting I
Biochem Biophys Res Commun; 1999 Oct; 263(3):843-7. PubMed ID: 10512768
[TBL] [Abstract][Full Text] [Related]
7. Genes of SHR rats protect spontaneously diabetic BB/OK rats from diabetes: lessons from congenic BB.SHR rat strains.
Klöting I; van den Brandt J; Kuttler B
Biochem Biophys Res Commun; 2001 May; 283(2):399-405. PubMed ID: 11327715
[TBL] [Abstract][Full Text] [Related]
8. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats.
Schröder D; Hehmke B; Klöting I; Schmidt S
Diabetes Res; 1991 Jun; 17(2):81-91. PubMed ID: 1817815
[TBL] [Abstract][Full Text] [Related]
9. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide produced by macrophages mediates suppression of ConA-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat.
Lee KU
Diabetes; 1994 Oct; 43(10):1218-20. PubMed ID: 7926291
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic insulin treatment of diabetes-prone BB/OK rats by application of a sustained release insulin implant.
Schröder D; Ratke M; Bauer UC; Klöting I; Ziegler B; Schmidt S
Autoimmunity; 2002 Mar; 35(2):143-53. PubMed ID: 12071437
[TBL] [Abstract][Full Text] [Related]
12. Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells.
Kuttler B; Wanka H; Hahn HJ
Transplantation; 1997 Aug; 64(3):480-9. PubMed ID: 9275116
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the multifunctional transcription factor Yy1 and type 1 diabetes mellitus in the BB rat.
Klöting N; Klöting I
Mol Genet Metab; 2004 Jul; 82(3):255-9. PubMed ID: 15234341
[TBL] [Abstract][Full Text] [Related]
14. Cytokine sensitivity of Langerhans' islets of diabetes-prone BB/OK rats under hypoglycemic conditions.
Schröder D; Wachlin G; Klöting I; Schmidt S
Autoimmunity; 2003 Jun; 36(4):211-9. PubMed ID: 14563014
[TBL] [Abstract][Full Text] [Related]
15. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD
Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902
[TBL] [Abstract][Full Text] [Related]
16. Humoral-mediated anti-islet cytotoxicity in diabetes-prone BB/OK rats--effect on beta-cell function and autologous islets.
Schröder D; Hehmke B; Klöting I; Besch W; Schmidt S
Exp Clin Endocrinol; 1990 Feb; 95(1):22-30. PubMed ID: 2185938
[TBL] [Abstract][Full Text] [Related]
17. Prospective investigations of long-term normoglycaemic BB/OK-rats: serial determination of glucose tolerance, insulitis, B-cell volume density and pancreatic insulin content.
Hahn HJ; Lucke S; Klöting I; Besch W
Exp Clin Endocrinol; 1991; 98(3):185-92. PubMed ID: 1778238
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer of viral interleukin-10 to BB rat islets: no protection after transplantation to diabetic BB rats.
Kuttler B; Wanka H; Klöting N; Gerstmayer B; Volk HD; Sawitzki B; Ritter T
J Cell Mol Med; 2007; 11(4):868-80. PubMed ID: 17760846
[TBL] [Abstract][Full Text] [Related]
19. Effects of a protective hydrolyzed casein diet upon the metabolic and secretory responses of pancreatic islets to IL-1beta, cytokine production by mesenteric lymph node cells, mitogenic and biosynthetic activities in Peyer's patch cells, and mitogenic activity in pancreatic lymph node cells from control and diabetes-prone BB rats.
Olivares E; Ladrière L; Laghmich A; Sener A; Malaisse WJ; Scott FW
Mol Genet Metab; 1999 Nov; 68(3):379-90. PubMed ID: 10562466
[TBL] [Abstract][Full Text] [Related]
20. Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains.
Klöting N; Follak N; Klöting I
Physiol Genomics; 2005 Dec; 24(1):59-64. PubMed ID: 16189279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
